A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

Condition:   Diabetic Foot Ulcer (DFU) Interventions:   Biological: APO-2;   Other: Placebo Sponsors:   Aposcience AG;   FGK Clinical Research GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials